Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway

類似資料

• Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer
  著者:: De Velasco, Marco A., 等
  出版事項: (2016)
• Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
  著者:: Yamamoto, Yutaka, 等
  出版事項: (2015)
• Phosphatase PTEN is Critically Involved in Post-Myocardial Infarction Remodeling through the Akt/Interleukin-10 Signaling Pathway
  著者:: Parajuli, Nirmal, 等
  出版事項: (2012)
• Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines
  著者:: Wang, Yu, 等
  出版事項: (2010)
• Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer
  著者:: De Velasco, Marco A., 等
  出版事項: (2014)